Researchers at the University of California, San Diego School of Medicine have shown that a new imaging dye, designed and developed at UC San Diego Moores Cancer Center, is an effective agent in detecting and mapping cancers that have reached the lymph nodes. The radioactive dye, called Technetium Tc-99m tilmanocept, successfully identified cancerous lymph nodes and did a better job of marking cancers than the current standard dye. Read more here.
Study mentioned: Wallace AM, et al. Comparative Evaluation of [99mTc] Tilmanocept for Sentinel Lymph Node Mapping in Breast Cancer Patients: Results of Two Phase 3 Trials. Ann Surg Oncol. 2013 Mar 17. [Epub ahead of print] PMID: 23504141
No comments:
Post a Comment